AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
DIFFERENCE BETWEEN EXPRESSION OF ADHESION MOLECULES ON CD34(-MARROW AND G-CSF-STIMULATED PERIPHERAL-BLOOD() CELLS FROM BONE)
Authors: KROGER N ZELLER W HASSAN HT DIERLAMM J ZANDER AR
Citation: N. Kroger et al., DIFFERENCE BETWEEN EXPRESSION OF ADHESION MOLECULES ON CD34(-MARROW AND G-CSF-STIMULATED PERIPHERAL-BLOOD() CELLS FROM BONE), Stem cells, 16(1), 1998, pp. 49-53
SUCCESSFUL MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN HEAVILY PRETREATED MYELOMA PATIENTS WITH G-CSF ALONE
Authors: KROGER N ZELLER W HASSAN HT KRUGER W RENGES H HUMMEL K GUTENSOHN K LOLLIGER C ZANDER AR
Citation: N. Kroger et al., SUCCESSFUL MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN HEAVILY PRETREATED MYELOMA PATIENTS WITH G-CSF ALONE, Annals of hematology, 76(6), 1998, pp. 257-262
G-CSF (24-MU-G KG) ALONE VERSUS CHEMOTHERAPY WITH DEXA-BEAM PLUS G-CSF (5-MU-G/KG) IN MOBILIZING PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH MALIGNANT-LYMPHOMA/
Authors: KROGER N ZELLER W FEHSE N HASSAN HT KRUGER W GUTENSHON K LOLLIGER C",MAAS,"KUHNL P ZANDER AR
Citation: N. Kroger et al., G-CSF (24-MU-G KG) ALONE VERSUS CHEMOTHERAPY WITH DEXA-BEAM PLUS G-CSF (5-MU-G/KG) IN MOBILIZING PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH MALIGNANT-LYMPHOMA/, Bone marrow transplantation, 21, 1998, pp. 370-370
THE SUBSET OF CD34 POSITIVE CELLS COEXPRESSING THE CD86 COSTIMULATORYMOLECULE IS ONE LOG LESS IN G-CSF-MOBILIZED LEUKAPHERESIS PRODUCTS COMPARED TO BONE-MARROW HARVESTS FROM HEALTHY DONORS
Authors: HASSAN HT GUTENSOHN K KROGER N KUHNL P ZANDER AR
Citation: Ht. Hassan et al., THE SUBSET OF CD34 POSITIVE CELLS COEXPRESSING THE CD86 COSTIMULATORYMOLECULE IS ONE LOG LESS IN G-CSF-MOBILIZED LEUKAPHERESIS PRODUCTS COMPARED TO BONE-MARROW HARVESTS FROM HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 667-667
DIVERGENT EFFECT OF TAXOL ON PROLIFERATION, APOPTOSIS AND NITRIC-OXIDE PRODUCTION IN MHH225 CD34 POSITIVE AND U937 CD34 NEGATIVE HUMAN LEUKEMIA-CELLS
Authors: ALALAMI O SAMMONS J MARTIN JH HASSAN HT
Citation: O. Alalami et al., DIVERGENT EFFECT OF TAXOL ON PROLIFERATION, APOPTOSIS AND NITRIC-OXIDE PRODUCTION IN MHH225 CD34 POSITIVE AND U937 CD34 NEGATIVE HUMAN LEUKEMIA-CELLS, Leukemia research, 22(10), 1998, pp. 939-945
MOBILIZING PERIPHERAL-BLOOD STEM-CELLS WITH HIGH-DOSE G-CSF ALONE IS AS EFFECTIVE AS WITH DEXA-BEAM PLUS G-CSF IN LYMPHOMA PATIENTS
Authors: KROGER N ZELLER W FEHSE N HASSAN HT KRUGER W GUTENSOHN K LOLLIGER C ZANDER AR
Citation: N. Kroger et al., MOBILIZING PERIPHERAL-BLOOD STEM-CELLS WITH HIGH-DOSE G-CSF ALONE IS AS EFFECTIVE AS WITH DEXA-BEAM PLUS G-CSF IN LYMPHOMA PATIENTS, British Journal of Haematology, 102(4), 1998, pp. 1101-1106
SCHEDULE-DEPENDENCY OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN BREAST-CANCER PATIENTS
Authors: KROGER N ZELLER W HASSAN HT KRUGER W LOLIGER C ZANDER AR
Citation: N. Kroger et al., SCHEDULE-DEPENDENCY OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN BREAST-CANCER PATIENTS, Blood, 91(5), 1998, pp. 1828-1828
ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS())
Authors: STOCKSCHLADER M HASSAN HT ZELLER W KRUGER W CLAUSEN J LOLIGER C DIECK AT KROGER N LINK H KABISCH H HOSSFELD DK ZANDER A
Citation: M. Stockschlader et al., ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS()), Leukemia & lymphoma, 25(1-2), 1997, pp. 145-151
HEMATOPOIETIC CYTOKINES IN THE BIOLOGY AND TREATMENT OF ACUTE MYELOID-LEUKEMIA - PERSPECTIVES AND CONTROVERSIES
Authors: HASSAN HT ZANDER AR
Citation: Ht. Hassan et Ar. Zander, HEMATOPOIETIC CYTOKINES IN THE BIOLOGY AND TREATMENT OF ACUTE MYELOID-LEUKEMIA - PERSPECTIVES AND CONTROVERSIES, Oncology Reports, 4(6), 1997, pp. 1141-1149
FACTORS INFLUENCING HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE
Authors: HASSAN HT KROG C STOCKSCHLADER M ZELLER W KRUGER W ERTTMANN R ZANDER AR
Citation: Ht. Hassan et al., FACTORS INFLUENCING HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE, Supportive care in cancer, 5(4), 1997, pp. 299-306
WEEKLY FEEDING WITH STEM-CELL FACTOR PLUS INTERLEUKIN-3 PLUS INTERLEUKIN-11 EXPANDS LTC-IC IN CORD-BLOOD CD34 POSITIVE CELLS CULTURED FOR 5WEEKS ON HUMAN BONE-MARROW STROMA
Authors: HASSAN HT PLANTHOLZ D ZANDER AR
Citation: Ht. Hassan et al., WEEKLY FEEDING WITH STEM-CELL FACTOR PLUS INTERLEUKIN-3 PLUS INTERLEUKIN-11 EXPANDS LTC-IC IN CORD-BLOOD CD34 POSITIVE CELLS CULTURED FOR 5WEEKS ON HUMAN BONE-MARROW STROMA, Experimental hematology, 25(8), 1997, pp. 342-342
FACTORS INFLUENCING THE HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE
Authors: HASSAN HT KROG C STOCKSCHLADER M SCHLEIMER B ZELLER W KRUGER W ERTTMANN R ZANDER AR
Citation: Ht. Hassan et al., FACTORS INFLUENCING THE HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE, Anticancer research, 17(1B), 1997, pp. 589-599
FIBRONECTIN INCREASES BOTH NONADHERENT CELLS AND CFU-GM WHILE COLLAGEN INCREASES ADHERENT CELLS IN HUMAN NORMAL LONG-TERM BONE-MARROW CULTURES
Authors: HASSAN HT SADOVINKOVA EY DRIZE NJ ZANDER AR NETH R
Citation: Ht. Hassan et al., FIBRONECTIN INCREASES BOTH NONADHERENT CELLS AND CFU-GM WHILE COLLAGEN INCREASES ADHERENT CELLS IN HUMAN NORMAL LONG-TERM BONE-MARROW CULTURES, Haematologia, 28(2), 1997, pp. 77-84
LONG-TERM FOLLOW-UP OF LEUKEMIA PATIENTS AFTER RELATED CRYOPRESERVED ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M HASSAN HT KROG C KRUGER W LOLIGER C HORSTMAN M ALTNODER M CLAUSEN J GRIMM J KABISCH H ZANDER A
Citation: M. Stockschlader et al., LONG-TERM FOLLOW-UP OF LEUKEMIA PATIENTS AFTER RELATED CRYOPRESERVED ALLOGENEIC BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 96(2), 1997, pp. 382-386
FACTORS INFLUENCING THE PLATELET RECOVERY AFTER AUTOLOGOUS G-CSF-MOBILIZED PBPC TRANSPLANTATION FOLLOWING MYELOABLATIVE THERAPY IN 50 HEAVILY PRETREATED LYMPHOMA PATIENTS
Authors: HASSAN HT HINZ T KROGER N KRUGER W ZANDER AR
Citation: Ht. Hassan et al., FACTORS INFLUENCING THE PLATELET RECOVERY AFTER AUTOLOGOUS G-CSF-MOBILIZED PBPC TRANSPLANTATION FOLLOWING MYELOABLATIVE THERAPY IN 50 HEAVILY PRETREATED LYMPHOMA PATIENTS, Blood, 90(10), 1997, pp. 4367-4367
MAINTENANCE AND EXPANSION OF ERYTHROPOIESIS IN HUMAN LONG-TERM BONE-MARROW CULTURES IN PRESENCE OF ERYTHROPOIETIN PLUS STEM-CELL FACTOR ANDINTERLEUKIN-3 OR INTERLEUKIN-11
Authors: HASSAN HT BIERMANN B ZANDER AR
Citation: Ht. Hassan et al., MAINTENANCE AND EXPANSION OF ERYTHROPOIESIS IN HUMAN LONG-TERM BONE-MARROW CULTURES IN PRESENCE OF ERYTHROPOIETIN PLUS STEM-CELL FACTOR ANDINTERLEUKIN-3 OR INTERLEUKIN-11, European cytokine network, 7(2), 1996, pp. 129-136
INTERFERON-ALPHA ENHANCES THE CYTOTOXIC AND CYTOSTATIC ACTIVITIES OF CHEMOTHERAPEUTIC DRUGS IN HUMAN MYELOID-LEUKEMIA CELLS
Authors: HASSAN HT GRELL S BORRMANNDANSO U FREUND M
Citation: Ht. Hassan et al., INTERFERON-ALPHA ENHANCES THE CYTOTOXIC AND CYTOSTATIC ACTIVITIES OF CHEMOTHERAPEUTIC DRUGS IN HUMAN MYELOID-LEUKEMIA CELLS, Journal of interferon & cytokine research, 16(2), 1996, pp. 139-146
COMPARISON BETWEEN BONE-MARROW AND G-CSF-MOBILIZED PERIPHERAL-BLOOD ALLOGRAFTS UNDERGOING CLINICAL-SCALE CD34(+) CELL SELECTION
Authors: HASSAN HT ZELLER W STOCKSCHLADER M KRUGER W HOFFKNECHT MM ZANDER AR
Citation: Ht. Hassan et al., COMPARISON BETWEEN BONE-MARROW AND G-CSF-MOBILIZED PERIPHERAL-BLOOD ALLOGRAFTS UNDERGOING CLINICAL-SCALE CD34(+) CELL SELECTION, Stem cells, 14(4), 1996, pp. 419-429
EX-VIVO EXPANSION OF PRE-CFU-S AND CFU-GM FROM CD34 POSITIVE HUMAN UMBILICAL-CORD BLOOD-CELLS
Authors: HASSAN HT PLANTHOLZ D ZANDER AR
Citation: Ht. Hassan et al., EX-VIVO EXPANSION OF PRE-CFU-S AND CFU-GM FROM CD34 POSITIVE HUMAN UMBILICAL-CORD BLOOD-CELLS, Experimental hematology, 24(9), 1996, pp. 5-5
WHITE BLOOD-CELL COUNT AT DAY OF LEUKAPHERESIS DETERMINES THE CD34 POSITIVE CELL CONTENT OF THE ALLOGRAFTS COLLECTED FROM HEALTHY DONORS FOR TRANSPLANTATION
Authors: HUMMEL K HASSAN HT GUTENSOHN K ZANDER AR KUHNL P
Citation: K. Hummel et al., WHITE BLOOD-CELL COUNT AT DAY OF LEUKAPHERESIS DETERMINES THE CD34 POSITIVE CELL CONTENT OF THE ALLOGRAFTS COLLECTED FROM HEALTHY DONORS FOR TRANSPLANTATION, Experimental hematology, 24(9), 1996, pp. 98-98
COMPARISON OF THE CONTENT AND SUBPOPULATIONS OF CD3 AND CD34 POSITIVECELLS IN MARROW HARVESTS AND G-CSF-MOBILIZED PB LEUKAPHERESIS FROM HEALTHY DONORS
Authors: HASSAN HT STOCKSCHLADER M SCHLEIMER B KRUGER W ZANDER AR
Citation: Ht. Hassan et al., COMPARISON OF THE CONTENT AND SUBPOPULATIONS OF CD3 AND CD34 POSITIVECELLS IN MARROW HARVESTS AND G-CSF-MOBILIZED PB LEUKAPHERESIS FROM HEALTHY DONORS, Experimental hematology, 24(9), 1996, pp. 140-140
THE DELAYED PLATELET RECOVERY AFTER ALLOGENEIC CORD-BLOOD TRANSPLANTATION COULD BE DUE TO AN INADEQUATE NUMBER OF CD34+CD41+ CELLS IN ALLOGRAFTS
Authors: HASSAN HT BEGEMANN P SCHLEIMER B ZANDER AR
Citation: Ht. Hassan et al., THE DELAYED PLATELET RECOVERY AFTER ALLOGENEIC CORD-BLOOD TRANSPLANTATION COULD BE DUE TO AN INADEQUATE NUMBER OF CD34+CD41+ CELLS IN ALLOGRAFTS, Experimental hematology, 24(9), 1996, pp. 264-264
THE DOSE OF BFU-E IN THE ALLOGRAFT DETERMINES PLATELET RECOVERY AFTERALLOGENEIC BONE-MARROW TRANSPLANTATION IN 76 LEUKEMIA PATIENTS
Authors: HASSAN HT KROG C STOCKSCHLADER M HOFFKNECHT MM KRUGER W ZELLER W ZANDER AR
Citation: Ht. Hassan et al., THE DOSE OF BFU-E IN THE ALLOGRAFT DETERMINES PLATELET RECOVERY AFTERALLOGENEIC BONE-MARROW TRANSPLANTATION IN 76 LEUKEMIA PATIENTS, Experimental hematology, 24(9), 1996, pp. 593-593
PURGING AND PROGENITOR SELECTION BY CD34-SEPARATION - A COMPARISON OF3 DEVICES()
Authors: KRUGER WH GRUBER M STOCKSCHLADER M HENNINGS S FEHSE N SCHLEIMER B HASSAN HT GUTENSOHN K LOLIGER C ZANDER AR
Citation: Wh. Kruger et al., PURGING AND PROGENITOR SELECTION BY CD34-SEPARATION - A COMPARISON OF3 DEVICES(), Experimental hematology, 24(9), 1996, pp. 603-603
USE OF CRYOPRESERVED DONOR BONE-MARROW IN 42 ALLOGENEIC TRANSPLANTATIONS
Authors: STOCKSCHLADER M HASSAN HT HORSTMANN M KROG K KRUGER W DEWIT M FIEDLER W ERTTMANN R ZANDER A
Citation: M. Stockschlader et al., USE OF CRYOPRESERVED DONOR BONE-MARROW IN 42 ALLOGENEIC TRANSPLANTATIONS, Experimental hematology, 24(9), 1996, pp. 666-666
Risultati: 1-25 | 26-45